Tocilizumab

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Tocilizumab (INN, or atlizumab, developed by Hoffmann La Roche and Chugai under the trade names Actemra and RoActemra) is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R) used as an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis. Interleukin 6 is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.

mgk tickets to my downfall, książka na prezent dla mężczyzny, książki o mafii erotyk pdf pl, włoszki, kredy, słup soli, ósme życie

yyyyy

Literatura obcojęzyczna